Chapter 13

Provide an overview of dopaminergic agonist agents (PowerPoint Slide 35; Learning Objective 3) Discuss the core drug knowledge related to fenoldopam (PowerPoint Slides 36 and 37; Learning Objectives 3 and 4) Pharmacotherapeutics . Pharmacokinetics. Pharmacodynamics. Contraindications and precautions. Adverse effects. Drug interactions ................
................